AKT inhibition in the central nervous system induces signaling defects resulting in psychiatric symptomatology.
Apostolia-Maria TsimberidouAntonis SklirisAlan ValentineJamie ShawUrsula HeringHenry Hiep VoTung On ChanRoger S ArmenJeffrey R CottrellJen Q PanPhilip N TsichlisPublished in: Cell & bioscience (2022)
Our data elucidate the incidence and mechanisms of psychiatric AEs in patients treated with PI3K/AKT/mTOR inhibitors and emphasize the need for careful monitoring.